Trexquant Investment LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$286,671
-19.2%
7,446
-67.9%
0.01%
-71.4%
Q3 2021$355,000
-1.7%
23,213
-27.0%
0.03%
+7.7%
Q1 2020$361,000
+86.1%
31,793
+3.2%
0.03%
+116.7%
Q4 2018$194,000
+31.1%
30,810
+175.1%
0.01%
+9.1%
Q3 2018$148,00011,1980.01%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders